Convelo is Biotechnology in United States that focus on new myelin business. Founded in 2016. They cover business area such as operator, medicine, neurological disease, novel drug candidate, oligodendrocyte progenitor cell, define drug-target, medical researcher, nerve cell, multiple sclerosis, pediatric leukodystrophie, traumatic injury, age-relate pathology, Alzheimer.
2016
( 8 years old in 2024 )
New Myelin
-
11000 Cedar Avenue
Cleveland, OH 44106
United States
Private
operatormedicineneurological diseasenovel drug candidateoligodendrocyte progenitor celldefine drug-targetmedical researchernerve cellmultiple sclerosispediatric leukodystrophietraumatic injuryage-relate pathologyAlzheimer
* We use standard office opening hours in near Convelo's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Convelo is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Convelo business is focusing on New Myelin.
Convelo headquarter office and corporate office address is located in 11000 Cedar Avenue Cleveland, OH 44106 United States.
Convelo was founded in United States.
In 2024, Convelo is currently focus on new myelin sector.
Above is snippet of Google Trends for "new myelin" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Convelo, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
